2-[(3-Carboxy-1-oxoprogy1) amino]-2-deoxy-D-glucose induces apoptosis in Hep G2 cells

Experimental Oncology

Volumn 27, Issue 1, 2005, Pages 52-55

  Wu, Jing ^a,b   Qi, Delu ^c   Wei, Kou ^d   Li, Juan ^a   Chen, Xuan ^a   Wang, Aiqing ^b   Liu, Weiming ^b   Xue, Qunji ^b   Qiao, Liang ^a,e  

^a LANZHOU UNIVERSITY   (China)

^b LANZHOU INSTITUTE OF CHEMICAL PHYSICS   (China)

^c People's Hospital of Lintao County   (China)

^d Med Coll of NW Minorities Univ ^*  (China)

^e UNIVERSITY OF SYDNEY   (Australia)

Author keywords

2 (3 carboxy 1 oxoprogy1)amino 2 deoxy D glucose; Apoptosis; COPADG; Hep G2; Hepatoma

Indexed keywords

2 [(3 CARBOXY 1 OXOPROGY1)AMINO]DEOXYGLUCOSE; ANTINEOPLASTIC AGENT; DNA FRAGMENT; GLUCOSE DERIVATIVE; UNCLASSIFIED DRUG;

AGAR GEL ELECTROPHORESIS; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CELL PROLIFERATION; CELL STRAIN HEPG2; CONCENTRATION RESPONSE; CONTROLLED STUDY; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; TRANSMISSION ELECTRON MICROSCOPY;

APOPTOSIS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL PROLIFERATION; DEOXYGLUCOSE; FLOW CYTOMETRY; HUMANS; LIVER NEOPLASMS; MICROSCOPY, ELECTRON, TRANSMISSION;

EID: 17444369361     PISSN: 02043564     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Chabicovsky M, Wastl U, Taper H, Grasl-Kraupp B, Schulte-Hermann R, Bursch W. Induction of apoptosis in mouse liver adenoma and carcinoma in vivo by transforming growth factor-beta 1. J Cancer Res Clin Oncol 2003; 129: 536-42.
2. Thompson HJ, Strange R, Schedin PJ. Apoptosis in the genesis and prevention of cancer. Cancer Epidemiol Biomarkers Prev 1992; 1: 597-603.
3. Ciardiello F, Caputo R, Bianco R, Damiano V, Pomatico G, De Placido S, Bianco AR, Tortora G. Antitumor effect and potentiation of cytotoxic drugs activity in human cancer cells by 2D-1839 (Iressa), an epidermal growth factor receptor-selective tyrosine kinase inhibitor. Clin Cancer Res 2000; 6: 2053-63.
4. Huang S, Armstrong EA, Benavente S, Chinnaiyan P, Harari PM. Dual-agent molecular targeting of the epidermal growth factor receptor (EGFR): combining anti-EGFR antibody with tyrosine kinase inhibitor. Cancer Res 2004; 64: 5355-62.
5. Philchenkov A, Zavelevich M, Kroczak TJ, Los M. Caspases and cancer: mechanisms of inactivation and new treatment modalities. Exp Oncol 2004; 26: 82-97.
6. Thompson CB. Apoptosis in the pathogenesis and treatment of disease. Science 1995; 267: 1456-62.
7. Fulda S, Debatin KM. Apoptosis signaling in tumor therapy. Ann N Y Acad Sci 2004; 1028: 50-6.
8. Wang Z, Qiao Y, Sheng HG. Glucosamine and glucosamine hydrochloride induced leukemia cell line K562 differentiation into macrophage. Chinese Pharmacol Bulletin 2003; 19: 290-3.
9. Wu J, Lu H, Zhou Y, Qiao L, Ji R, Wang A-Q, Liu W-M, Xue Q-J. Effect of 2-(3-carboxy-1-oxopropy1) amino-2-deoxy-D-glucose on human esophageal cancer cell line. World J Gastroenterol 2004; 10: 3380-1.
10. Qiao L, Farrell GC. The effects of cell density, attachment substratum and dexamethasone on spontaneous apoptosis of rat hepatocytes in primary culture. In Vitro Cell Dev Biol Anim 1999: 35: 417-24.
11. Yang L, Cao Z, Yan H, Wood WC. Coexistence of high levels of apoptotic signaling and inhibitor of apoptosis proteins in human tumor cells: implication for cancer specific therapy. Cancer Res 2003; 63: 6815-24.